NSEUpdates1d ago · 17 Sept 2026, 04:56 pm
Updates
Fischer Medical Ventures Limited · FISCHER
✦ AI SummaryResults
Fischer Medical Ventures Limited has informed the Exchange regarding 'Presentation of Investor/Analyst meeting' and submitted a revised presentation as required under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk2/10
Liquidity Impact8/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Fischer Medical Ventures Limited has informed the Exchange regarding 'Presentation of Investor/Analyst meeting'.
Attachments (1)
📄pdf
Download →
FISCHER_17092026165507_Revised_Presentation_to_SE_17092026.pdf
View document text
FISCHER MEDICAL VENTURES LIMITED
Registered Office Address: Survey No. 480/2 AP Medtech Zone,
Nadupura Village, Pedagantyadu Mandal, Visakhapatnam, 530032
CIN: L86900AP1993PLC118162
Email: cs@fischermv.com | Website: www.fischermv.com | Contact 9080966548
September 17, 2026
To To
BSE Limited National Stock Exchange of India Ltd. Exchange
Corporate Relationship Department Plaza, 5tll floor
25th Floor, P J Towers Plot No. C/ 1, G Block,
Dalal Street, Fort, Bandra-Kurla Complex Bandra (E),
Mumbai – 400 001 Mumbai - 400 051
BSE Scrip Code: 524743 NSE Symbol: FISCHER
Dear Sir/ Madam,
Sub: Submission of revised presentation as required under Regulation 30 of SEBI (Listing
Obligations and Disclosure Requirements) Regulations, 2015
With reference to our presentation dated September 7, 2026 in terms of Regulation 30 and other applicable
provisions of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements)
Regulations, 2015, as amended, please find enclosed copy of the revised presentation for the
Investor/Analyst call held on September 7, 2026.
This is for the information of the exchange and the members.
Thanking you,
Yours Truly,
For FISCHER MEDICAL VENTURES LIMITED
BALAJI GANDLA
COMPANY SECRETARY AND COMPLIANCE OFFICER
Corporate Office: Level 8, Prestige Palladium Bayan, No. 129-140 Greams Road, Chennai, Tamil Nadu, 600006
INVESTOR& STRATEGPIACR TNERSHIPPR ESENTATION
Fischer MedLiimciatle dV entures
Builtdhiweno gr llda'rsg est
HealtAhlSc oalruePt liaotfonrsm
Al-enMaebdlieIcdma alg IiPn ogup latioSnc-rseceaInlHi eosn ipgt Dailg itization
June 2026 Confnitldi DeaoI Not Distribute
LEGALN OTICE
Disclaimer
InformMaetmioorna npdruemp afroeFrdi scher Medical Ventures Limited
PREPARBEYD
FiscMheedri Vceanlt ures
• Purp&oS sceo pe • DuDei lig&e nRcAiecs kkn owledgement
Potenitnivaels tsotrsr aaptnaedrtg niaecrr aesd vitsoe dp etrfhoeoriwmrn d udei ligaencndoc nes ult
Thei nformpartioovnii tnd heIidns f ormMaetmioorna nidfsuo imron rfmatipounraplo ses
witqhu alfiifniaenldce igoaarill n, v estamdevnibtse ofromsra ek ianndgye cisbiaosonensdt he
onlanyds hounolt bde c onsidaneo rffereo drs olciitatot enigoangi nae n iyn vestment contoefnt thpsir se senItnavteisotnim.nhe enatlst theccahrneom leodgiiycm,aa lg ainnAdgl -enabled
or fintarnacnisaarellc attitoeoF dni scher MedicalT hVimesen motraunrdeusm Limdiitaegdnp.ol sattificon rhmesrc eanrrtryil syak nspd,a psetrf onremieans o atr eliianbdlieoca ftf ourt ure
has benep repaerd byF sicher Medurisec aLli mtoVi oetffneeatdcr o mprehensive resultsc.o nMdairrtkeiegotun lsfa,rt aomrye waonrtdke sc hncyocllocegasycn h anrgaep idly,
overvoifie tbwsu sinessa,n dpp elorarftmfaon-rc bmuet i nso ti enntdetdos ervea sa impacbtuisnigon uetscso amnefdsi nancial returns.
standailnovnees tment guide.
• Accur&a Pcrye limEisntairmya tes • LimitoafLt iiaobni lity
WhileF ischer Muerdsei cLailsm tiVrteifenvdoate rcs c urinat chpyer esenotfa tion
Iti ess senttoai cakln owtlhetvad agrei asbulcaehsms a kreftul ctuarteigounlsa,t ory
finandcaitaraldo, u cdpte tarielgsu,la aptopovrrya alndsm arkientf ormaalftlii gounr,e s
changpersjeoc,tt i melainnuden sf oreospeeerna tcihoanlalclea n ingneflsu ethnec e
andst atiasrtei csstuo bc jheacnwtgi et hporruin too tiAncy per.o vifidneadn ecsitailm ates
compapneyrfo'rsm anFcsicehe.r Medical Vaendn its tuarsescisota eeLdni timieitst ed
aerp rleiminard ysh oaunnlodtb ei ntreertapesfid n l aofferTsh.eu ltiamtfiena nctiearlm s
discla liima bfoairnil yniatcyc uormaiscisioenosrst, y pograerprhotirhcsmaa atl yb e
wil ble detearttmh ietn iemodf ef romalc ontargaerecmte nt.
presenti n dtohcieusnmt.
Bya ccestshidinosgc ument, atchkneo wrleaedndpadgic eecesnpt tth tsee nnssefo tr tahb o.v e
June 2026 ConfidIeDnot iNDaoilts tribute
DISRUPTIVTEE CHNOLOGIES
ProprietarSyt aTcekc hnology
Six pillarbse spto-wiienmr-aicgpnlieganrf sgos r mance A WhyoO lwlned Subosfi/'d EJ!ia£!!!!r!y
0 0 0
Magnet Technology RF TCeocihln ology ConsToelceh nology
■ Perma&n eLTn0St. 35T/ ■ Multi-channel phased ■arraUynifsiceadnp nliantgf orm
0.71T./S T/3.0T ■ Multi-fnruecqluceeoini clys ■ Remodtiea gsnuoposprtis
■ Cryogemna-gfnreetes ■ HTS coil architecture ■ AdvanGcUewIdo rkflow
■ HTuStl ra-fhiieglhd
Imaging TechnologyG radTieecnhtn ology AlT echnology
■ Fasstceatrmni e s ■ Al-assiimsatgeidn g
■ High-pergfroardmiaennctes
■ Higrheesro lution ■ Autsoc anning
■ Fasitmearg ciyncgl es
■ Noirseed uc&ta idoanpf tiilvtee r ■ Pre-drieaagdn ostics
KEY TAKEAVWeArYt iicnatlelgyrI aPat cerdom sasg nectosig,lr sa,d iceonntssoi,lm aeg,ai nndAg l - a defenasgiabiclnoesm tmm oodaitt ized
OEMs.
June 2026 ConfidIDe on tDNiioastlt ribute
DIRECTORS
FMV List of Directors
Board of Directors
Whole Time Director
Chairman & Managing Director Independent Director
Svetlana Rao Raviwada
Ravindran Govindan Khairy Jamaluddin Abu Bakar
• Electronics & Communications Engineer with prior
• Former Chairman & President (APAC), Fisher Scientific • Former Minister of Health, Malaysia
roles at Wipro & Alcatel R&D
Inc. • Led national COVID-19 response and digital healthcare
• Led establishment of FMV India operations
• 45+ years across healthcare, investments & technology initiatives
• Oversees India business strategy and operations
• Early investor and strategic advisor to Time Medical • Brings Southeast Asian healthcare policy and
Group governance expertise
June 2026 Confidential | Do Not Distribute
DIRECTORS
FMV List of Directors
Board of Directors
Independent Director Independent Director
Independent Director
Ms. Jaya Ankur Singhania Mr. Richard Chan Sing En Dr. Syed Jalaluddin
• 15+ years in corporate governance and legal advisory • 30+ years in private equity and corporate finance • Distinguished academic, scientist & corporate leader
• Expertise in compliance, CSR, IP rights & board • Extensive experience across Southeast Asia & Australia • Contributor to Malaysia's halal ecosystem and Islamic
governance • Provides strategic financial and investment advisory banking sector
• Supports regulatory oversight and governance insights • Brings deep technical, scientific and governance
frameworks expertise
June 2026 Confidential | Do Not Distribute
DIRECTORS
FMVKMP
KeMya nagerial Personal- FMV Group
FMVG roCuhpiO epfe rating FMGVr oupF iCnhainecfi al ChiTeechfn olOoffgiycTi emre- Chief OOfpfiecreTiarmt-eMi endgi cal
Officer Officer Medical
Shankar VajarnadharaVivBeakl asubramanian SimYoenu ng AmoMlh askar
• 30y+e airnis ns vtement • CharteAcroceutdnna tw ith, • Co-foouTfni dmMeeer d ical•Ovre y1e3a orefsx e prtiisnFe id el
bankijnetgcf ,i nparnocingh,avgpi ernviowuosrlkayetP dW C Systweimotsveh 2r 0 y eaorfs Engeirnisenpge,c iiaMnlR iIz eismnsyg,s t
ansdt ralteeeagrdsihci p adn KPaMsaGl eiaMnde rgers experiinMe RnsIcy es tem porjemcatn amgeenatn,cd u stosmeerrv ice,
• Exrpieeea nccrsoescst ors andA cquitseiatmi.ons develowpimteehxn tte,n sivweiatfo hc uosnm eetdienagd aldnines
inclbuadnikntigeen lcgo,m , • Heh sa a tsrtarrcoeknc ogof rd operatcioomnmael,ar, nc dial driignov preatisocuencsasl.
tecphwo,ee rt c. succeasdsvfiuisdlniale snlyfo g r idnusterxipaelra icernocses •Succfeulslesladynm den torteaedm osf
laediPnEgVs Cs, acnodor rpations haehlctamraer ski etnth UeS A, FideE lgnineMeanrietsan,n cTceenh icians,
int hIesT, t uaprastn adu toobmile Eur&oC phei na. optimriseuzoricuneltg ii zaantdion
sectors. improevffiincgi ency
June 2026 ConfidIDe on tDNiioastlt ribute